Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
07/04/2002 | WO2002012274A3 Iapl-3 a protein inhibitor of apoptosis proteins |
07/04/2002 | WO2002002624A3 B7-like molecules and uses thereof |
07/04/2002 | WO2001094400A3 A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF |
07/04/2002 | WO2001092492A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
07/04/2002 | WO2001090148A8 Neurotransmitter transporters |
07/04/2002 | WO2001083515A3 Simulated activity of protein a displayed by ligands attached to a cellulose bead surface |
07/04/2002 | WO2001081414A3 Integrin alpha subunit and uses thereof |
07/04/2002 | WO2001079481A3 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides |
07/04/2002 | WO2001078779A3 Antibody alpha4beta7 integrin and its use to treat inflammatory bowel disease |
07/04/2002 | WO2001078768A3 Targeted vaccine delivery systems |
07/04/2002 | WO2001077169A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
07/04/2002 | WO2001070266A3 Method of inhibiting stenosis and restenosis with a mixture of antibodies anti cd18 and anti ccr2 |
07/04/2002 | WO2001068855A3 Gtp-binding protein gamma-12 subunit |
07/04/2002 | WO2001055364A3 Nucleic acids, proteins, and antibodies |
07/04/2002 | WO2001055328A3 Nucleic acids, proteins, and antibodies |
07/04/2002 | WO2001055325A3 Nucleic acids, proteins, and antibodies |
07/04/2002 | WO2001055322A3 Nucleic acids, proteins, and antibodies |
07/04/2002 | WO2001055321A3 Nucleic acids, proteins, and antibodies |
07/04/2002 | WO2001055318A3 Nucleic acids, proteins, and antibodies |
07/04/2002 | WO2001055311A3 Nucleic acids, proteins, and antibodies |
07/04/2002 | WO2001055308A3 Nucleic acids, proteins, and antibodies |
07/04/2002 | WO2001046420A8 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
07/04/2002 | WO2001036589A9 Human ex vivo immune system |
07/04/2002 | WO2001032673A9 Sequences encoding human neoplastic marker |
07/04/2002 | WO2000069891A9 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
07/04/2002 | WO2000068242A9 Collagen-binding proteins from enterococcal bacteria |
07/04/2002 | WO2000050081A9 Product and method for treatment of conditions associated with receptor-desensitization |
07/04/2002 | WO2000022430A9 Neisseria genomic sequences and methods of their use |
07/04/2002 | US20020088016 Murine expression of a human IgA lambda locus |
07/04/2002 | US20020086987 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders |
07/04/2002 | US20020086978 Specific binding agents |
07/04/2002 | US20020086972 Adaptor protein FRS2 and related products and methods |
07/04/2002 | US20020086897 Cytotoxic agents comprising taxanes and their therapeutic use |
07/04/2002 | US20020086848 Associated with Fanconi anaemia (FA), a genetic disease; antibodies, gene therapy |
07/04/2002 | US20020086847 DNA encoding a recombinant antibody molecule end-specific for an amyloid-beta peptide for preventing or inhibiting progression of Alzheimer's Disease |
07/04/2002 | US20020086845 Rat PTTG polypeptide and method for producing it |
07/04/2002 | US20020086841 Naked DNA construct encoding a cytokine selected from macrophage inflammatory protein-1 alpha, monocyte chemoattractant protein 1, and tumor necrosis factor-alpha, linked to a viral transcription control sequence, and carrier |
07/04/2002 | US20020086838 Such as antibodies, proteins, drugs such as spironolactone, imidapril, an angiotensin converting enzyme inhibitor, captopril, enalapril, defibrotide, and angiotensin II receptor antagonist |
07/04/2002 | US20020086831 Methods and use of motoneuronotrophic factors |
07/04/2002 | US20020086830 (HARC), and polynucleotides which encode it; agonists, antibodies, or antagonists specifically binding HARC, and their use in treating diseases associated with expression of HARC |
07/04/2002 | US20020086827 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity |
07/04/2002 | US20020086826 Antibodies against ligand for receptor activator of NF-kB |
07/04/2002 | US20020086444 Isolated menbrane protein for use in the diagnosis and treatment of alzheimer's disease |
07/04/2002 | US20020086414 Novel ctla4/cd28 ligands and uses therefor |
07/04/2002 | US20020086408 Ubiquitin-like conjugating protein |
07/04/2002 | US20020086403 Polypeptide for use in the treatment and prevention of viral infections and cancer |
07/04/2002 | US20020086385 Nucleotide sequences coding enzyymatic polypeptide for use in prevention of bacterial infection; bactericides |
07/04/2002 | US20020086381 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
07/04/2002 | US20020086379 Human membrane-spanning proteins |
07/04/2002 | US20020086360 Polypeptide for use in treatment of congestive heart failure, ischaemic heart defects, arrhytmias, cardioiomyopathy and stroke |
07/04/2002 | US20020086352 Methods for expressing endostatin protein |
07/04/2002 | US20020086335 Nanoparticle for use as biosensors in the detection of nucleic acids, antigens, enzymes and enzyme substrates |
07/04/2002 | US20020086320 Detecting prostate cancer gene in test sample; obtain nucleotide sequence sample, incubate with probe, detect signal for from probes bound to target sequences |
07/04/2002 | US20020086316 Reagents and methods useful for detecting diseases of the prostate |
07/04/2002 | US20020086305 Human c-Maf compositions and methods of use thereof |
07/04/2002 | US20020086301 Reagents and methods useful for detecting diseases of the prostate |
07/04/2002 | US20020086283 Immunogen |
07/04/2002 | US20020086276 Immunotherapeutic methods for extracorporeal modulation of CD36 and its ligands |
07/04/2002 | US20020086034 Compositions and methods for treating viral infections |
07/04/2002 | US20020086030 Preparations and methods for the treatment of t cell mediated diseases |
07/04/2002 | US20020086025 Antibodies that bind to alpha2-antiplasmin crosslinked to fibrin which do not inhibit plasma alpha2-antiplasmin |
07/04/2002 | US20020086024 RatB polypeptides and DNA (RNA) encoding ratB polypeptides producing such polypeptides by recombinant techniques; utilizing ratB polypeptides to screen for antibacterial compounds. |
07/04/2002 | US20020086023 Streptococcal streptolysin S vaccines |
07/04/2002 | US20020086022 A target antigen is mixed with a heterologous antisera specific or cross-reactive to that antigen to produce an inoculant. |
07/04/2002 | US20020086020 Method for improving the half-life of soluble viral receptors on mucosal membranes |
07/04/2002 | US20020086019 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances |
07/04/2002 | US20020086014 Human sequence antibody that specifically binds to human CTLA-4; nucleic acid encoding a heavy chain of a human sequence antibody; polyvalent complex; transgenic non-human; treating an autoimmune disease |
07/04/2002 | US20020086011 Administering an effective amount of an OX-2 protein or a nucleic acid encoding an OX-2 protein; use to suppress an immune response and to prevent or treat autoimmune disease, especially arthritis. |
07/04/2002 | US20020086009 Anti-phosphorylated tau protein antibodies and methods for detecting alzheimer`s disease with the use of the same |
07/04/2002 | US20020086008 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
07/04/2002 | US20020086007 Angiogenesis-inhibiting peptides and proteins and methods of use |
07/04/2002 | DE10157336A1 Diagnosing pancreatic disorders, particularly pancreatitis, by detecting, in body fluid, proteolysis fragments of exocrine pancreatic proteins |
07/04/2002 | DE10037759A1 Screeningverfahren Screening method |
07/04/2002 | CA2782510A1 Polypeptides |
07/04/2002 | CA2432591A1 A novel human leucine-rich repeat containing protein expressed predominately in bone marrow, hlrrbm1 |
07/04/2002 | CA2432380A1 Sugar beet genes involved in stress tolerance |
07/04/2002 | CA2432214A1 Gene involved in apoptosis regulation |
07/04/2002 | CA2432168A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
07/04/2002 | CA2430930A1 Helicobacter proteins, nucleic acids and uses thereof |
07/03/2002 | EP1219710A1 Novel polypeptides and genes encoding the same |
07/03/2002 | EP1219638A2 G-protein coupled receptors having homology to the P2Y purinoreceptor 1 (P2Y1) |
07/03/2002 | EP1219637A1 Polypeptides having a triggering NK activity and biological applications |
07/03/2002 | EP1218538A2 Cancer associated antigens and uses therefor |
07/03/2002 | EP1218520A1 Checkpoint gene associated cell cycle proteins, compositions and methods of use |
07/03/2002 | EP1218519A1 Enzyme which cleaves ester groups and which is derived from thermomonospora fusca |
07/03/2002 | EP1218518A1 Dna polymerase lambda and uses thereof |
07/03/2002 | EP1218515A2 Regulation with binding cassette transporter protein abc1 |
07/03/2002 | EP1218511A1 Antimicrobial compositions |
07/03/2002 | EP1218509A2 Fibroblast growth factor-like polypeptides |
07/03/2002 | EP1218507A1 Monoclonal antibody 3f1h10 neutralising vhsv (viral haemorrhagic septicaemia virus) |
07/03/2002 | EP1218506A1 Traf4 associated cell cycle proteins, compositions and methods of use |
07/03/2002 | EP1218505A2 Syk kinase-associated cell cycle proteins, compositions and methods of use |
07/03/2002 | EP1218504A2 Gl50 molecules and uses therefor |
07/03/2002 | EP1218501A1 Creation of variable length and sequence linker regions for dual-domain or multi-domain molecules |
07/03/2002 | EP1218491A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
07/03/2002 | EP1218414A2 Polypeptides for detection and elimination of ca19-9 antigen positive cells |
07/03/2002 | EP1218413A2 Engineering antibodies that bind irreversibly |
07/03/2002 | EP1218412A2 Human g-protein coupled receptor |
07/03/2002 | EP1218409A2 Factor-h related protein 5 (fhr-5) and antibodies thereto |
07/03/2002 | EP1218408A1 32 human secreted proteins |